Mckesson Medical-Surgical Inc. Corporate Office recalls Hylenex recombinant (hyaluronidase) injection
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- cGMP Deviations: Temperature excursion
- Products
-
- Hylenex recombinant (hyaluronidase) injection
- Where it was sold
-
Virgina
- Units affected
- 5 cartons/20 units each carton
- About this recall
- Hylenex recombinant (hyaluronidase) injection, 150 USP units/mL, 4x1 mL Single Dose Vials, Rx only, Manufactured for and marketed by Halozyme, Inc., 12390 El Camino Real San Diego California 92130, Distributed by Antares Pharma, Inc., Ewing, NJ NDC 18657-117-04